Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:1034-1040

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plato, C. F.
Right arrow Articles by Osborn, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plato, C. F.
Right arrow Articles by Osborn, J. L.

(Hypertension. 1996;28:1034-1040.)
© 1996 American Heart Association, Inc.


Articles

Chronic Renal Neuroadrenergic Hypertension Is Associated With Increased Renal Norepinephrine Sensitivity and Volume Contraction

Craig F. Plato; Jeffrey L. Osborn

the Department of Physiology and Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee.

Individuals with essential hypertension have been characterized by increased renal sympathetic vascular tone with decreased plasma volume and normal cardiac output compared with normotensive individuals. We used a servo-controlled intrarenal infusion system to evaluate the hemodynamic, renal excretory, and plasma hormonal responses to 28-day, low-level elevations in the intrarenal adrenergic neurotransmitter norepinephrine. In uninephrectomized dogs (n=6), servo-controlled norepinephrine infusion increased mean arterial pressure from 95.6±3.1 to 115.7±4.9 mm Hg on day 1 without concomitant reductions in renal blood flow. Arterial hypertension was sustained and renal vascular resistance increased during the 28 days of servo-controlled norepinephrine infusion despite significant decreases in the daily dose of intrarenal norepinephrine (1.49±0.23 to 0.47±0.25 mg/d) necessary to maintain renal blood flow constant. Arterial pressure returned to control values with the cessation of servo-controlled norepinephrine, whereas renal blood flow and renal vascular resistance remained slightly decreased and increased, respectively. Cumulative sodium balance exhibited a net 177±37 mmol sodium loss over the 28 days of norepinephrine infusion, indicating that the hypertension did not result from sodium retention or expansion of extracellular fluid volume. Intrarenal norepinephrine did not change plasma epinephrine, norepinephrine, or vasopressin concentrations. Atrial natriuretic factor, however, increased at 7 and 14 days of servo-controlled norepinephrine, and plasma renin activity increased on day 14 of norepinephrine infusion. We conclude that low-level elevation of intrarenal adrenergic neurotransmitter produces sustained arterial hypertension that is independent of expansion in extracellular fluid volume, increases in circulating catecholamines or plasma renin activity, or reductions in renal blood flow. This hypertension may be associated with increased renal vascular sensitivity to norepinephrine and/or other renal vasoactive factors.


Key Words: hypertension, essential • kidney • sympathetic nervous system • norepinephrine • sodium




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
O. Grisk and R. Rettig
Interactions between the sympathetic nervous system and the kidneys in arterial hypertension
Cardiovasc Res, February 1, 2004; 61(2): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. C. Malpas
What sets the long-term level of sympathetic nerve activity: is there a role for arterial baroreceptors?
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R1 - R12.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. J. Barrett, R. Ramchandra, S.-J. Guild, A. Lala, D. M. Budgett, and S. C. Malpas
What Sets the Long-Term Level of Renal Sympathetic Nerve Activity: A Role for Angiotensin II and Baroreflexes?
Circ. Res., June 27, 2003; 92(12): 1330 - 1336.
[Abstract] [Full Text] [PDF]